Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Braintree Laboratories |
---|---|
Information provided by: | Braintree Laboratories |
ClinicalTrials.gov Identifier: | NCT00164164 |
The purpose of the this study was to compare the safety and efficacy of HalfLytely (2L NULYTELY + 20mg bisacodyl) to NULYTELY for preparation prior to colonoscopy.
Condition | Intervention | Phase |
---|---|---|
Colonoscopy |
Drug: HalfLytely Drug: NuLytely |
Phase III |
Study Type: | Interventional |
Study Design: | Randomized, Single Blind, Active Control, Parallel Assignment |
Official Title: | HalfLytely Bowel Prep System for Colonoscopy |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
United States, Massachusetts | |
Braintree, Massachusetts, United States, 02184 | |
United States, Texas | |
San Antonio, Texas, United States, 78284 |
Principal Investigator: | Charles Brady, MD | University of Texas Health Science Center San Antonio |
Study ID Numbers: | F38-20 |
Study First Received: | September 9, 2005 |
Last Updated: | September 9, 2005 |
ClinicalTrials.gov Identifier: | NCT00164164 History of Changes |
Health Authority: | United States: Food and Drug Administration |
colonoscopy preparation prep |